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Aims & Objectives: 
Gestational diabetes mellitus (GDM) is believed to result when a genetic predisposition is 
perpetuated by an increase in insulin resistance during pregnancy. However, in the subjects with 
GDM in our population, little is known about the genetic basis of MODY and its potential clinical 
significance. Due to an overlap of clinical features with the more common polygenic type 2 
diabetes (T2D) and type 1 diabetes (T1D),  the differentiation of patients with maturity onset 
diabetes of the young (MODY) is a diagnostic challenge. Therefore, we aimed to screen 
pregnant women with diabetes for a comprehensive panel of ten MODY genes utilizing next 
generation sequencing (NGS). Further, among the T2D diabetogenic genes, the common 
variants of TCF7L2 have been shown to be associated with T2D in Asian-Indian population. Our 
aim was also to investigate whether these TCF7L2 variants associated with T2D would also 
confer risk for gestational diabetes mellitus. 
Material and Methods: 
We included 50 south Indian women with diabetes complicating their pregnancy to screen for 
mutations in a comprehensive panel of ten MODY genes [HNF1A, HNF4A, GCK, PDX1, HNF1B, 
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NEUROD1, KLF11, CEL, PAX4 and INS]. A novel multiplex polymerase chain reaction (PCR) 
based target enrichment followed by NGS on the Ion Torrent Personal Genome Machine (PGM). 
The detected rare variants which were of pathogenic significance were confirmed by Sanger 
sequencing and genotype phenotype correlation was done. Further, in 166 unrelated women 
(117 women with gestational diabetes mellitus, 49 ethnically matched non-diabetic control 
subjects) DNA extraction was done using the Gentrapuregene blood method. The primers were 
validated by Sanger sequencing (3130 genetic analyzer) and genotyped 3 TCF7L2 
polymorphisms (rs7903146, rs12255372 and rs4506565) using TaqMan allelic discrimination 
assay. The data was analysed using SPSS version 16.0. 
 Results: 
Mutations were identified in 16% (8/50) of the subjects screened. There were two mutations in 
NEUROD1, two in PDX1, one each in HNF1A, GCK, CEL and INS genes. Seven of these 
mutations were novel. We further proceeded to identify and confirm the presence of these 
mutations in the relatives of some of these patients and also the neonates.  We have found that 
the odds ratio (OR) of TCF7L2 polymorphisms rs4506565, rs7903146, rs12255372 for the 
occurrence of gestational diabetes when compared with controls were 3.75(C.I=0.75-
18.53,p=0.08), 1.77 (C.I=0.503-6.263,p=0.37) and 1.40 (C.I=0.24-8.11, P=0.70) respectively. 
Conclusions: 
Pregnant women of Asian Indian origin harbor a higher frequency of NEUROD1 and PDX1 
mutations, a pattern that differs from the western literature.  The NGS platform provides an 
accurate, rapid and cost effective method for parallelized genetic testing for MODY and 
hence overcomes the inherent limitation of scalability and cost of Sanger sequencing. The 
TCF7L2 polymorphism rs4506565 has showed a strong trend towards association with the 
occurrence of gestational diabetes, when compared to the other two common polymorphisms in 
TCF7L2 (rs7903146, rs12255372). This is the first preliminary data of TCF7L2 polymorphism 
associations with gestational diabetes in a south Indian population. 
